JP2019506175A5 - - Google Patents

Download PDF

Info

Publication number
JP2019506175A5
JP2019506175A5 JP2018544819A JP2018544819A JP2019506175A5 JP 2019506175 A5 JP2019506175 A5 JP 2019506175A5 JP 2018544819 A JP2018544819 A JP 2018544819A JP 2018544819 A JP2018544819 A JP 2018544819A JP 2019506175 A5 JP2019506175 A5 JP 2019506175A5
Authority
JP
Japan
Prior art keywords
seq
signal peptide
nucleic acid
ige signal
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018544819A
Other languages
English (en)
Japanese (ja)
Other versions
JP7012365B2 (ja
JP2019506175A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/019407 external-priority patent/WO2017147458A1/en
Publication of JP2019506175A publication Critical patent/JP2019506175A/ja
Publication of JP2019506175A5 publication Critical patent/JP2019506175A5/ja
Priority to JP2021189383A priority Critical patent/JP7555325B2/ja
Application granted granted Critical
Publication of JP7012365B2 publication Critical patent/JP7012365B2/ja
Priority to JP2024073806A priority patent/JP2024096281A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018544819A 2016-02-25 2017-02-24 ジカウイルスに対する新規のワクチン Active JP7012365B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021189383A JP7555325B2 (ja) 2016-02-25 2021-11-22 ジカウイルスに対する新規のワクチン
JP2024073806A JP2024096281A (ja) 2016-02-25 2024-04-30 ジカウイルスに対する新規のワクチン

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201662300030P 2016-02-25 2016-02-25
US62/300,030 2016-02-25
US201662305183P 2016-03-08 2016-03-08
US62/305,183 2016-03-08
US201662396742P 2016-09-19 2016-09-19
US62/396,742 2016-09-19
US201662417100P 2016-11-03 2016-11-03
US62/417,100 2016-11-03
US201762462249P 2017-02-22 2017-02-22
US62/462,249 2017-02-22
PCT/US2017/019407 WO2017147458A1 (en) 2016-02-25 2017-02-24 Novel vaccines against zika virus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021189383A Division JP7555325B2 (ja) 2016-02-25 2021-11-22 ジカウイルスに対する新規のワクチン

Publications (3)

Publication Number Publication Date
JP2019506175A JP2019506175A (ja) 2019-03-07
JP2019506175A5 true JP2019506175A5 (enExample) 2020-04-02
JP7012365B2 JP7012365B2 (ja) 2022-03-04

Family

ID=59685658

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018544819A Active JP7012365B2 (ja) 2016-02-25 2017-02-24 ジカウイルスに対する新規のワクチン
JP2021189383A Active JP7555325B2 (ja) 2016-02-25 2021-11-22 ジカウイルスに対する新規のワクチン
JP2024073806A Pending JP2024096281A (ja) 2016-02-25 2024-04-30 ジカウイルスに対する新規のワクチン

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021189383A Active JP7555325B2 (ja) 2016-02-25 2021-11-22 ジカウイルスに対する新規のワクチン
JP2024073806A Pending JP2024096281A (ja) 2016-02-25 2024-04-30 ジカウイルスに対する新規のワクチン

Country Status (10)

Country Link
US (2) US11648303B2 (enExample)
EP (1) EP3419660A4 (enExample)
JP (3) JP7012365B2 (enExample)
KR (1) KR20190003471A (enExample)
CN (2) CN115927399A (enExample)
AU (3) AU2017222644B2 (enExample)
BR (1) BR112018017307A2 (enExample)
CA (1) CA3015792A1 (enExample)
MX (2) MX2018010291A (enExample)
WO (1) WO2017147458A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA42502A (fr) 2015-07-21 2018-05-30 Modernatx Inc Vaccins contre une maladie infectieuse
US11364292B2 (en) 2015-07-21 2022-06-21 Modernatx, Inc. CHIKV RNA vaccines
EP3364950A4 (en) 2015-10-22 2019-10-23 ModernaTX, Inc. VACCINES AGAINST TROPICAL DISEASES
WO2017147458A1 (en) * 2016-02-25 2017-08-31 The Trustees Of The University Of Pennsylvania Novel vaccines against zika virus
CA3040123A1 (en) * 2016-10-11 2018-04-19 University Of Miami Vectors and vaccine cells for immunity against zika virus
US11806393B2 (en) * 2017-02-10 2023-11-07 La Jolla Institute For Allergy And Immunology Flavivirus peptide sequences, epitopes, and methods and uses thereof
WO2018151816A1 (en) 2017-02-16 2018-08-23 Modernatx, Inc. High potency immunogenic compositions
US10653767B2 (en) 2017-09-14 2020-05-19 Modernatx, Inc. Zika virus MRNA vaccines
CA3081586A1 (en) 2017-11-03 2019-05-09 Takeda Vaccines, Inc. Zika vaccines and immunogenic compositions, and methods of using the same
CN116983398A (zh) 2017-11-30 2023-11-03 武田疫苗股份有限公司 寨卡疫苗和免疫原性组合物以及其使用方法
US11491217B2 (en) 2017-12-06 2022-11-08 Emory University Chimeric viruses encoding mutant zika virus envelope glycoproteins
BR112021001195A2 (pt) * 2018-07-23 2021-04-27 The University Of Adelaide vacina, composição farmacêutica, peptídeo imunogênico isolado, composição, métodos para elicitar uma resposta imune em um sujeito, para produzir um anticorpo antiproteína ns1 de zika, para detectar uma infecção por zica vírus e para detectar células t específicas de zika vírus, e, uso de uma vacina, uma composição farmacêutica, um peptídeo imunogênico isolado ou uma composição.
WO2020092564A1 (en) * 2018-10-31 2020-05-07 Icahn School Of Medicine At Mount Sinai Human antibodies targeting zika virus ns1, ns1 polypeptides and uses thereof
WO2020190750A1 (en) 2019-03-15 2020-09-24 Modernatx, Inc. Hiv rna vaccines
WO2022169339A1 (ko) * 2021-02-05 2022-08-11 에스티팜 주식회사 신규 핵산 분자

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU774045B2 (en) * 1998-09-02 2004-06-17 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Dengue viruses that are replication defective in mosquitos for use as vaccines
US7767210B2 (en) * 2005-12-14 2010-08-03 The Board Of Regents Of The University Of Oklahoma RNA virus vaccines and methods
CN101909635B (zh) * 2008-01-11 2014-09-17 Vgx药品有限责任公司 针对多种登革病毒亚型的新颖疫苗
US8961994B2 (en) 2008-11-17 2015-02-24 Vgx Pharmaceuticals, Llc DNA constructs eliciting immune response against flavivirus and effective adjuvants
CN102821790A (zh) * 2009-09-14 2012-12-12 宾夕法尼亚大学托管会 包含IL-15受体α和/或编码IL-15受体α的核酸分子的疫苗和免疫治疗剂,以及其使用方法
KR101851699B1 (ko) 2009-11-02 2018-04-24 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 구제역 바이러스(ｆｍｄｖ) 공통 단백질, 이를 위한 코딩 서열 및 이로부터 만들어진 백신
US8691961B1 (en) 2009-11-09 2014-04-08 Integral Molecular, Inc. Flavivirus reporter virus and methods of making and using the same
WO2011115583A1 (en) * 2010-03-19 2011-09-22 National University Of Singapore A novel platform for retrovirus-like particle (vlp)-display of vaccine antigens
BR112012024224A2 (pt) * 2010-03-24 2016-11-29 Arbovax Inc mutações da faixa de hospedeiro de flavivírus e seu uso.
CN105821078A (zh) * 2010-12-09 2016-08-03 巴斯德研究所 用于获得高产量重组蛋白表达的基于mgmt的方法
EA033467B1 (ru) * 2011-01-31 2019-10-31 Univ Pennsylvania Молекула нуклеиновой кислоты для индукции иммунного ответа против герпесвируса и ее применение
JP6215223B2 (ja) * 2011-12-09 2017-10-18 アンスティテュ・パストゥール マルチプレックス免疫スクリーニングアッセイ
US9987347B2 (en) * 2013-03-15 2018-06-05 The Trustees Of The University Of Pennsylvania Vaccines against multiple subtypes of dengue virus
JP6896700B2 (ja) * 2015-07-16 2021-06-30 バハラ バイオテック インターナショナル リミテッド ワクチン組成物
MA42502A (fr) 2015-07-21 2018-05-30 Modernatx Inc Vaccins contre une maladie infectieuse
EP3364950A4 (en) * 2015-10-22 2019-10-23 ModernaTX, Inc. VACCINES AGAINST TROPICAL DISEASES
US11723967B2 (en) * 2016-02-17 2023-08-15 CureVac SE Zika virus vaccine
WO2017147458A1 (en) * 2016-02-25 2017-08-31 The Trustees Of The University Of Pennsylvania Novel vaccines against zika virus
MX2019000725A (es) * 2016-07-18 2019-07-04 Variation Biotechnologies Inc Composiciones de vacuna para tratamiento de virus zika.
EP3515482A4 (en) * 2016-09-19 2020-09-30 The Wistar Institute Of Anatomy And Biology ASSOCIATION OF NEW ZIKA VIRUS VACCINES AND ANTI-DNA ANTIBODY CONSTRUCTIONS FOR USE AGAINST ZIKA VIRUS
BR112019014314A2 (pt) * 2017-01-11 2020-02-18 The Trustees Of The University Of Pennsylvania Composição, e, método de indução de uma resposta imune adaptativa contra vírus zika.
EP3412307A1 (en) * 2017-06-07 2018-12-12 Institut Pasteur Recombinant measles virus expressing zika virus proteins and their applications

Similar Documents

Publication Publication Date Title
Zens et al. Memory CD4 T cells in influenza
US12239699B2 (en) Immunogen for broad-spectrum influenza vaccine and application thereof
JP2015501656A5 (enExample)
JP6333730B2 (ja) 改善されたｉｌ−１２遺伝子構築物を含む組成物、及びそれを用いたワクチン、免疫治療剤及び方法
JP2012515557A5 (enExample)
JP2014534202A5 (enExample)
RU2677799C2 (ru) Модифицированные суперспиральные белки с улучшенными свойствами
FI3872085T3 (fi) Esimuotoiset virussekvenssit ja niiden käytöt
JP2014507146A5 (enExample)
JP2010516290A5 (enExample)
JP2009540801A5 (enExample)
JP2009544333A5 (enExample)
JP2015501840A5 (enExample)
JP2013507907A5 (enExample)
JP2016517414A (ja) インフルエンザ核酸分子及びそれから作製したワクチン
JP2013515747A5 (enExample)
JP2006514549A5 (enExample)
JP2011517938A5 (enExample)
WO2022071513A1 (ja) ＳＡＲＳ－ＣｏＶ－２に対する改良型ＤＮＡワクチン
CN103467571A (zh) 一种畜禽免疫增强剂法氏囊多肽
KR20180064158A (ko) 구제역 바이러스의 가용성 다가 항원단백질 및 이의 용도
CN106282178A (zh) 重组嗜酸乳杆菌s层蛋白在大肠杆菌中的高效表达及其应用
CN103173455B (zh) 一种具有抗新城疫病毒活性的鹅源基因rig-i及其应用
JP2013545735A (ja) インフルエンザウィルスの組換えヘマグルチニン蛋白質及びそれを含むワクチン
JP2013504600A5 (enExample)